Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. (Q34128899)

31 July 2017

title

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. (English)

1 reference

31 July 2017

0 references

1 reference

Timothy C Fabian

1 reference

31 July 2017

G Christopher Wood

1 reference

31 July 2017

Scott D Hanes

series ordinal

1 reference

31 July 2017

Martin A Croce

series ordinal

1 reference

31 July 2017

Bradley A Boucher

series ordinal

1 reference

31 July 2017

language of work or name

English

0 references

publication date

30 April 2002

1 reference

Clinical Infectious Diseases

31 July 2017

published in

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

1425-1430

1 reference

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

31 July 2017

cites work

1 reference

Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group.

21 January 2018

1 reference

Problem pathogens (Pseudomonas aeruginosa and Acinetobacter).

21 January 2018

1 reference

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

21 January 2018

1 reference

Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus

21 January 2018

1 reference

Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group

21 January 2018

1 reference

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

21 January 2018

1 reference

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

21 January 2018

1 reference

Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients

21 January 2018

1 reference

Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam

21 January 2018

1 reference

Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam

21 January 2018

1 reference

Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

21 January 2018

1 reference

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/340055

1 reference

31 July 2017

1 reference